Literature DB >> 17290220

The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2.

Lauren F Stevenson1, Alison Sparks, Nerea Allende-Vega, Dimitris P Xirodimas, David P Lane, Mark K Saville.   

Abstract

Mdm2 is an E3 ubiquitin ligase that promotes its own ubiquitination and also ubiquitination of the p53 tumour suppressor. In a bacterial two-hybrid screen, using Mdm2 as bait, we identified an Mdm2-interacting peptide that bears sequence similarity to the deubiquitinating enzyme USP2a. We have established that full-length USP2a associates with Mdm2 in cells where it can deubiquitinate Mdm2 while demonstrating no deubiquitinating activity towards p53. Ectopic expression of USP2a causes accumulation of Mdm2 in a dose-dependent manner and consequently promotes Mdm2-mediated p53 degradation. This differs from the behaviour of HAUSP, which deubiquitinates p53 in addition to Mdm2 and thus protects p53 from Mdm2-mediated degradation. We further demonstrate that suppression of endogenous USP2a destabilises Mdm2 and causes accumulation of p53 protein and activation of p53. Our data identify the deubiquitinating enzyme USP2a as a novel regulator of the p53 pathway that acts through its ability to selectively target Mdm2.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17290220      PMCID: PMC1852834          DOI: 10.1038/sj.emboj.7601567

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  55 in total

1.  Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding.

Authors:  E Shaulian; A Zauberman; D Ginsberg; M Oren
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

2.  Regulation of p53 by the ubiquitin-conjugating enzymes UbcH5B/C in vivo.

Authors:  Mark K Saville; Alison Sparks; Dimitris P Xirodimas; Julie Wardrop; Lauren F Stevenson; Jean-Christophe Bourdon; Yvonne L Woods; David P Lane
Journal:  J Biol Chem       Date:  2004-07-26       Impact factor: 5.157

Review 3.  The p53-mdm2 autoregulatory feedback loop: a paradigm for the regulation of growth control by p53?

Authors:  S M Picksley; D P Lane
Journal:  Bioessays       Date:  1993-10       Impact factor: 4.345

Review 4.  Protein-protein interactions: methods for detection and analysis.

Authors:  E M Phizicky; S Fields
Journal:  Microbiol Rev       Date:  1995-03

5.  The p53-mdm-2 autoregulatory feedback loop.

Authors:  X Wu; J H Bayle; D Olson; A J Levine
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

6.  The isopeptidase USP2a protects human prostate cancer from apoptosis.

Authors:  Carmen Priolo; Dan Tang; Mohan Brahamandan; Barbara Benassi; Ewa Sicinska; Shuji Ogino; Antonella Farsetti; Alessandro Porrello; Stephen Finn; Johann Zimmermann; Phillip Febbo; Massimo Loda
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

7.  Identification of novel mdm2 binding peptides by phage display.

Authors:  V Böttger; A Böttger; S F Howard; S M Picksley; P Chène; C Garcia-Echeverria; H K Hochkeppel; D P Lane
Journal:  Oncogene       Date:  1996-11-21       Impact factor: 9.867

8.  Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53.

Authors:  J D Oliner; J A Pietenpol; S Thiagalingam; J Gyuris; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

9.  Mice with reduced levels of p53 protein exhibit the testicular giant-cell degenerative syndrome.

Authors:  V Rotter; D Schwartz; E Almon; N Goldfinger; A Kapon; A Meshorer; L A Donehower; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

10.  mdm2 expression is induced by wild type p53 activity.

Authors:  Y Barak; T Juven; R Haffner; M Oren
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

View more
  130 in total

1.  USP2a protein deubiquitinates and stabilizes the circadian protein CRY1 in response to inflammatory signals.

Authors:  Xin Tong; Katie Buelow; Anirvan Guha; Rebecca Rausch; Lei Yin
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

Review 2.  Emerging role of Lys-63 ubiquitination in protein kinase and phosphatase activation and cancer development.

Authors:  W-L Yang; X Zhang; H-K Lin
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

3.  Regulation of p53 stability and function by the deubiquitinating enzyme USP42.

Authors:  Andreas K Hock; Arnaud M Vigneron; Stephanie Carter; Robert L Ludwig; Karen H Vousden
Journal:  EMBO J       Date:  2011-11-15       Impact factor: 11.598

Review 4.  The role of deubiquitinating enzymes in apoptosis.

Authors:  Suresh Ramakrishna; Bharathi Suresh; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2010-08-21       Impact factor: 9.261

Review 5.  Decision for cell fate: deubiquitinating enzymes in cell cycle checkpoint.

Authors:  Key-Hwan Lim; Myoung-Hyun Song; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2016-01-13       Impact factor: 9.261

Review 6.  The p53 orchestra: Mdm2 and Mdmx set the tone.

Authors:  Mark Wade; Yunyuan V Wang; Geoffrey M Wahl
Journal:  Trends Cell Biol       Date:  2010-02-19       Impact factor: 20.808

7.  JTV1 co-activates FBP to induce USP29 transcription and stabilize p53 in response to oxidative stress.

Authors:  Juhong Liu; Hye-Jung Chung; Matthew Vogt; Yetao Jin; Daniela Malide; Liusheng He; Miroslav Dundr; David Levens
Journal:  EMBO J       Date:  2011-02-01       Impact factor: 11.598

8.  Nonenzymatic rubylation and ubiquitination of proteins for structural and functional studies.

Authors:  Rajesh K Singh; Adithya Sundar; David Fushman
Journal:  Angew Chem Int Ed Engl       Date:  2014-04-24       Impact factor: 15.336

9.  Monoubiquitination is critical for ovarian tumor domain-containing ubiquitin aldehyde binding protein 1 (Otub1) to suppress UbcH5 enzyme and stabilize p53 protein.

Authors:  Yuhuang Li; Xiao-Xin Sun; Johannes Elferich; Ujwal Shinde; Larry L David; Mu-Shui Dai
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

10.  Ubiquitin-specific protease 39 is overexpressed in human lung cancer and promotes tumor cell proliferation in vitro.

Authors:  Zhifeng Lin; Liwen Xiong; Qiang Lin
Journal:  Mol Cell Biochem       Date:  2016-09-15       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.